| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 04/27/2011 | CN102036971A 3- or 4-substituted piperidine compounds |
| 04/27/2011 | CN101560190B Method for researching and controlling impurity E in Valsartan |
| 04/27/2011 | CN101239942B Method for producing phthalocyanine compound and its intermediate, and intermediate compound for the same |
| 04/26/2011 | US7932279 Substituted tetrazole compounds and uses thereof |
| 04/26/2011 | US7932252 CCR9 chemokine receptor modulators; treating inflammatory and immune diseases; inhibit the binding of chemokines, such as TECK (thymus-expressed chemokine), to the CCR9 receptor; 1-arylsulfonamido-2-aryl(alkyl)benzene compounds |
| 04/26/2011 | CA2446778C Process for preparing polyisocyanates |
| 04/26/2011 | CA2345103C (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 04/21/2011 | WO2011046380A2 Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester |
| 04/21/2011 | WO2011005322A3 N-alkoxyamide conjugates as imaging agents |
| 04/21/2011 | US20110092551 Dual-acting imidazole antihypertensive agents |
| 04/21/2011 | US20110091541 Preparation of formulations of angiotensin II at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
| 04/21/2011 | CA2776743A1 Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester |
| 04/20/2011 | CN102026988A 3-substituted propanamine compounds |
| 04/20/2011 | CN101314595B Aromatic hydrocarbons connected multi-polyamine large-ring derivants, preparation method and medical use thereof |
| 04/19/2011 | US7928228 Triazolone derivatives |
| 04/19/2011 | US7928096 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same |
| 04/13/2011 | EP2307017A1 Compounds which can be used for the treatment of cancers |
| 04/13/2011 | CN102010381A Improved preparation method of valsartan |
| 04/13/2011 | CN101444496B Compounds for the treatment of metabolic disorders |
| 04/13/2011 | CN101270097B Process for production of 1-aryl-5-(trifluoromethyl)-1H-tetrazoles |
| 04/12/2011 | US7923567 Process for preparing valsartan |
| 04/12/2011 | US7923566 Alternative process for the preparation of losartan |
| 04/12/2011 | CA2481480C Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles |
| 04/12/2011 | CA2471099C .alpha.-(n-sulphonamido)acetamide derivatives as .beta.-amyloid inhibitors |
| 04/07/2011 | US20110082295 Novel curcumin derivative |
| 04/06/2011 | EP2305640A2 Substituted diphenyl-ethers, -amines, -sulfides and -methanes for the treatment of respiratory diseases |
| 04/06/2011 | EP1912956B1 Metal salts of 2'-(1h-tetraz0l-5-yl) -1,1'-biphenyl-4-carboxaldehyde |
| 04/06/2011 | CN102002008A 1-alkyl-1,6-dihydro-1,2,4,5-tetrazine compound and synthesis method thereof |
| 04/05/2011 | US7919506 Dibenzyl amine compounds and derivatives |
| 04/05/2011 | US7919071 Contrast agent |
| 03/31/2011 | WO2011036674A1 A new process for the preparation of olmesartan medoxomil |
| 03/30/2011 | EP1802297B1 Compositions and methods for treatment of disease caused by yersinia spp infection |
| 03/30/2011 | CN101993690A IIB metal organic complex fluorescent light-emitting material |
| 03/30/2011 | CN101993689A Rare-earth metal coordination polymer fluorescence luminescent material, and synthesis and application thereof |
| 03/30/2011 | CN101993422A Synthesis and application of blue-fluorescence luminous cadmium metal complex |
| 03/30/2011 | CN101993421A Synthesis and application of blue-fluorescence luminous zinc metal complex |
| 03/29/2011 | US7915425 Process for the preparation of losartan |
| 03/29/2011 | US7915402 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring |
| 03/24/2011 | WO2010108125A3 Psma-targeting compounds and uses thereof |
| 03/24/2011 | US20110071197 Bis-aryl compounds for use as medicaments |
| 03/23/2011 | EP2049467B1 Therapeutic amides and related compounds |
| 03/22/2011 | CA2513102C Substituted pyrazoles, compositions containing such compounds and methods of use |
| 03/17/2011 | WO2011031073A2 Novel tetra-aza macrocyclic compound, method for preparing same, and use thereof |
| 03/17/2011 | US20110064657 Labeled inhibitors of prostate specific membrane antigen (psma), biological evaluation, and use as imaging agents |
| 03/15/2011 | US7906501 Pyrrole derivatives with angiotensin II antagonist activity |
| 03/10/2011 | WO2011027888A1 Diamide-phenyl derivative and pharmaceutically acceptable salt thereof |
| 03/10/2011 | US20110059920 Agent for regeneration and/or protection of nerves |
| 03/09/2011 | EP2291076A1 Angiotensin ii receptor antagonists |
| 03/08/2011 | CA2488202C 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 03/08/2011 | CA2457061C Tetrazoyloxime derivative and agricultural chemical containing the same as active ingredient |
| 03/08/2011 | CA2422291C Targeted alpha particle therapy using actinium-225 conjugates |
| 03/03/2011 | WO2011022798A1 Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same |
| 03/03/2011 | US20110054066 Use of polymerizable macrocyclic polyethers and macrocyclic heteroanalogous polyethers in dental materials |
| 03/03/2011 | US20110053901 Acetyl mimic compounds for the inhibition of isoprenyl-s-cysteinyl methyltransferase |
| 03/03/2011 | US20110052674 Angiotensin ii receptor blocker derivatives |
| 03/03/2011 | CA2771044A1 Aralkyl benzyl ethers compounds, process for preparation thereof, intermediate compounds, use of such compounds, methods of treatment and/or prevention, pharmaceutical compositionand medicine containing the same |
| 03/02/2011 | EP2004601B1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them |
| 03/02/2011 | EP1901731B1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 03/01/2011 | US7897784 Process for preparing five-membered heterocyclyl tetracycline compounds and methods of use thereof |
| 03/01/2011 | US7897331 Process of using a tetrazolium salt |
| 02/24/2011 | US20110046147 17beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases |
| 02/23/2011 | EP2285787A2 3-substituted propanamine compounds |
| 02/22/2011 | US7893266 Detection of cancer cells in vitro using sigma-2 receptor ligands as radiotracers |
| 02/17/2011 | US20110039854 Linear and cyclic guanidine derivatives, method of preparation and uses thereof |
| 02/17/2011 | US20110039851 Ccr10 antagonists |
| 02/17/2011 | US20110038805 Compounds comprising paramagnetic chelates arranged around a central core and their use in magneto resonance imaging and spectroscopy |
| 02/16/2011 | EP1663105B1 Cycloalkyl heterocycles for treating hepatitis c virus |
| 02/16/2011 | EP1379498B1 Sulphones which modulate the action of gamma secretase |
| 02/16/2011 | CN101973950A Method for preparing HMX by dynamic material ratio technology |
| 02/15/2011 | USRE42152 FDA Orange book listed patent for plerixafor |
| 02/15/2011 | US7888380 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
| 02/15/2011 | CA2459724C Multi-use multimodal imaging chelates |
| 02/09/2011 | CN101970423A Fungicide hydroximoyl-tetrazole derivatives |
| 02/09/2011 | CN101970414A 1 ibeta-hydroxysteroid dehydrogenase inhibitors |
| 02/09/2011 | CN101970015A N-alkoxyamide conjugates as imaging agents |
| 02/09/2011 | CN101781264B Production method of 1-methyl-5-mercapto-1,2,3,4-tetrazole |
| 02/08/2011 | US7884118 such as 1-Cyclopentyl-5-iodotetrazole, suitable as microbicides for protecting plants and materials |
| 02/08/2011 | CA2355717C 1,2-annelated quinoline derivatives |
| 02/03/2011 | WO2011012777A1 Absorbent solution containing a degradation inhibitor derived from a triazole or from a tetrazole and process for the absorption of acid compounds contained in a gaseous effluent |
| 02/03/2011 | US20110028509 Sulfonamides |
| 02/03/2011 | CA2767338A1 Absorbent solution containing a degradation inhibitor derived from a triazole or from a tetrazole and process for the absorption of acid compounds contained in a gaseous effluent |
| 02/02/2011 | EP2279190A1 Compounds comprising paramagnetic chelates arranged around a central core and their use in magneto resonance imaging and spectroscopy |
| 02/02/2011 | CN101962319A Synthetic micromolecule compound capable of conveying bioactive substances and application thereof |
| 02/01/2011 | US7880015 Process for the preparation of angiotensin II antagonist |
| 02/01/2011 | US7880014 Angiotensin II receptor antagonists |
| 02/01/2011 | US7879893 Zinc binding ligand; sustained release of insulin |
| 02/01/2011 | US7879863 Aniline derivatives |
| 02/01/2011 | CA2555633C Non-nucleoside reverse transcriptase inhibitors |
| 02/01/2011 | CA2315717C Inhibition of raf kinase using substituted heterocyclic ureas |
| 01/27/2011 | US20110021765 Fluorinated lanthanide probes for 19f magnetic resonance applications |
| 01/26/2011 | EP2277875A2 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
| 01/26/2011 | EP2276752A1 Compound composed of a metal ion and a marker precursor having two or more targeting vectors, and use of the compound |
| 01/26/2011 | CN101955470A Potentiators of glutamate receptors |
| 01/26/2011 | CN101955469A Separation method of mixture of HMX and RDX |
| 01/26/2011 | CN101006064B Method for preparing irbesartan and intermediates thereof |
| 01/25/2011 | US7875641 new forms of 2-butyl-1-[2'-(1H-tetrazol-5-yl)bifenyl-4-yl-methyl]spiro[2-imidazoline-4.1'-cyclopentane]-5-one; antagonist of angiotensin-II receptors |
| 01/25/2011 | CA2552087C Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
| 01/20/2011 | WO2011006935A2 Tetrazole derivatives |
| 01/20/2011 | WO2009001375A3 Improved process for preparing pure valsartan |
| 01/20/2011 | US20110015403 Process for preparing iodinated azoles |